BAX602 in Preventing the Adhesion Around Great Cardiac Vessels in Pediatric Patients With Congenital Heart Disease Undergoing Re-do Open Heart Surgery (Japan Trial)

Exclusion Criteria

• •3. Patients who will undergo BT shunting or pulmonary artery banding (including bilateral pulmonary artery banding) for the first surgery
• •4. Patients undergoing repair surgery (anatomical repair surgery) or bi-directional Glenn surgery as the second target procedure
• •5. Patients for whom written consent has been obtained from the patient or a surrogate
• •1. Patients with hypoplastic left heart syndrome (HLHS) and its analogues.
• •2. Patients with asplenia or hypersplenism.
• •3. Patients undergoing Norwood surgery as the second surgery.
• •4. Patients undergoing open heart surgery prior to the first scheduled palliative surgery.
• •5. Patients with complications of other organs that affect the indication for cardiac surgery.
• •6. Patients with chromosomal or genetic abnormalities that may affect the indication for cardiac surgery.
• •7. Patients with severe infections or multiple organ failure.
• •8. Patients who require emergency surgery that requires emergency life support.
• •9. Patients' body weight is less than 2,500g at birth.
• •10. Patients who are participating in other clinical trials or who are scheduled to participate in other clinical trials during this study period.
• •11. Patients who are judged by the investigator or sub investigator to be inappropriate to participate in this study for other reasons.